Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Fixed dosage regimens for anti-type I interferon receptor (IFNAR) antibodies

Fixed dosage regimens for anti-type I interferon receptor (IFNAR) antibodies

US Patent 9493570 · Granted Nov 15, 2016

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Methods for characterizing compositions comprising peanut antigens2025
Reagent and method for fluorescence quantitative real-time PCR detection of RCL2025
Bispecific chimeric antigen receptors targeting CD20 and BCMA2025
Methods for determining treatment for cancer patients2025
Method of treating type 1 interferon (IFN)-mediated disease using a subcutaneous2024
Anti-B7-H1 antibodies for treating tumors2023
Anti-B7-H1 antibodies for treating tumors2023
Methods for quantifying drug concentration in a prodrug composition2023
Methods for determining treatment for cancer patients2023
Reagent and method for fluorescence quantitative real-time PCR detection of RCL2023
Combined chimeric antigen receptor targeting CD19 and CD20 and application there2023
Construction of chimeric antigen receptor targeting CD20 antigen and activity id2023